BioRestorative Announces FDA Clearance of IND for Phase 2 Trial of BRTX-100 in Chronic Cervical Discogenic Pain
– BRTX-100 is the first and only stem cell product candidate cleared…
Tag: Nasdaq:BRTX
– BRTX-100 is the first and only stem cell product candidate cleared…
